412 related articles for article (PubMed ID: 15122711)
1. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of Alpers syndrome.
Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
[TBL] [Abstract][Full Text] [Related]
3. POLG mutations and Alpers syndrome.
Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
[TBL] [Abstract][Full Text] [Related]
4. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2005 Sep; 58(3):491. PubMed ID: 16130100
[No Abstract] [Full Text] [Related]
5. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
Compton AG; Troedson C; Wilson M; Procopis PG; Li FY; Brundage EK; Yamazaki T; Thorburn DR; Wong LJ
Mitochondrion; 2011 Jan; 11(1):104-7. PubMed ID: 20708716
[TBL] [Abstract][Full Text] [Related]
6. POLG mutations in Alpers syndrome.
Nguyen KV; Østergaard E; Ravn SH; Balslev T; Danielsen ER; Vardag A; McKiernan PJ; Gray G; Naviaux RK
Neurology; 2005 Nov; 65(9):1493-5. PubMed ID: 16177225
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
[TBL] [Abstract][Full Text] [Related]
8. POLG1 mutations associated with progressive encephalopathy in childhood.
Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
[TBL] [Abstract][Full Text] [Related]
9. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
[TBL] [Abstract][Full Text] [Related]
10. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.
Wolf NI; Rahman S; Schmitt B; Taanman JW; Duncan AJ; Harting I; Wohlrab G; Ebinger F; Rating D; Bast T
Epilepsia; 2009 Jun; 50(6):1596-607. PubMed ID: 19054397
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
Cardenas JF; Amato RS
Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
[TBL] [Abstract][Full Text] [Related]
12. Consequences of mutations in human DNA polymerase gamma.
Longley MJ; Graziewicz MA; Bienstock RJ; Copeland WC
Gene; 2005 Jul; 354():125-31. PubMed ID: 15913923
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis.
Hance N; Ekstrand MI; Trifunovic A
Hum Mol Genet; 2005 Jul; 14(13):1775-83. PubMed ID: 15888483
[TBL] [Abstract][Full Text] [Related]
14. Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
Scalais E; Francois B; Schlesser P; Stevens R; Nuttin C; Martin JJ; Van Coster R; Seneca S; Roels F; Van Goethem G; Löfgren A; De Meirleir L
Eur J Paediatr Neurol; 2012 Sep; 16(5):542-8. PubMed ID: 22342071
[TBL] [Abstract][Full Text] [Related]
15. Alpers syndrome with mutations in POLG: clinical and investigative features.
Hunter MF; Peters H; Salemi R; Thorburn D; Mackay MT
Pediatr Neurol; 2011 Nov; 45(5):311-8. PubMed ID: 22000311
[TBL] [Abstract][Full Text] [Related]
16. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
Zsurka G; Baron M; Stewart JD; Kornblum C; Bös M; Sassen R; Taylor RW; Elger CE; Chinnery PF; Kunz WS
J Neuropathol Exp Neurol; 2008 Sep; 67(9):857-66. PubMed ID: 18716558
[TBL] [Abstract][Full Text] [Related]
17. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.
Chan SS; Longley MJ; Naviaux RK; Copeland WC
DNA Repair (Amst); 2005 Dec; 4(12):1381-9. PubMed ID: 16181814
[TBL] [Abstract][Full Text] [Related]
18. The unfolding clinical spectrum of POLG mutations.
Blok MJ; van den Bosch BJ; Jongen E; Hendrickx A; de Die-Smulders CE; Hoogendijk JE; Brusse E; de Visser M; Poll-The BT; Bierau J; de Coo IF; Smeets HJ
J Med Genet; 2009 Nov; 46(11):776-85. PubMed ID: 19578034
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study.
Hayhurst H; Anagnostou ME; Bogle HJ; Grady JP; Taylor RW; Bindoff LA; McFarland R; Turnbull DM; Lax NZ
Brain Pathol; 2019 Jan; 29(1):97-113. PubMed ID: 30021052
[TBL] [Abstract][Full Text] [Related]
20. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
Neeve VC; Samuels DC; Bindoff LA; van den Bosch B; Van Goethem G; Smeets H; Lombès A; Jardel C; Hirano M; Dimauro S; De Vries M; Smeitink J; Smits BW; de Coo IF; Saft C; Klopstock T; Keiling BC; Czermin B; Abicht A; Lochmüller H; Hudson G; Gorman GG; Turnbull DM; Taylor RW; Holinski-Feder E; Chinnery PF; Horvath R
Brain; 2012 Dec; 135(Pt 12):3614-26. PubMed ID: 23250882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
